We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (NASDAQ: VRTX). Compared to the S&P 500 index, which is down about ...

Damian Eallonardo has been promoted to President of W.E. O'Neil Construction overseeing Chicago. With more than three decades in the commercial construction industry and $4+ billion in projects ...

Over the past 15 years, Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products. CRISPR Therapeutics won its first regulatory ...

Vertex Pharmaceuticals (NASDAQ: VRTX) is a great example of biotech success. The company has built a cystic fibrosis (CF) empire, bringing in billions of dollars in revenue annually, and now is ...

President Donald Trump says he plans to impose tariffs on pharmaceuticals "very shortly," in what could be the next phase of his sweeping overhaul of global trade. President Donald Trump says he ...

Shares of Vertex Pharmaceuticals Inc. VRTX slid 1.41% to $475.49 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 3.46% ...

“Don’t get too close to the king,” cautioned The Mirror and the Light’s Damian Lewis, who returned to his role of King Henry VIII ten years after Wolf Hall’s award-winning run. In ...

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $475.49, marking a -1.41% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 3.46%.

In its first quarter 2025 investor letter, GreensKeeper Asset Management emphasized stocks such as Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Vertex Pharmaceuticals Incorporated (NASDAQ ...